Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL.

ABSTRACT:

SUBMITTER: Perez A 

PROVIDER: S-EPMC9278282 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature